FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

Kamala Harris Schedule Announcement Perfectly Personifies Contemptible Nature of Biden White House

Arizona Professor Shot To Death On Campus; Former Student Arrested After Hours-Long Search

DC Deputy Mayor Charged with Assault and Battery After Grabbing Man by His Neck in Gym Parking Lot

Joe Biden in Florida: ‘Biggest Thing’ Ron DeSantis Did During Hurricane Ian Was Recognize Global Warming

Saudi Arabia Helps Russia Cut Oil Output In Slight To United States, Sending Prices Soaring

Bidenomics Sends U.S. National Debt Soaring Past $31 Trillion for First Time

Stacey Abrams Claims She Never Denied 2018 Georgia Gubernatorial Election Outcome

Karine Jean-Pierre Grilled As Gas Prices Start To Surge Again: ‘It’s A Lot More Nuanced Than That’

5 Years After Las Vegas Concert Shooting, an FBI Whistleblower Reveals Probable Motive

Justice Ketanji Brown Jackson’s Twisted, New Comments Justifying ‘Race-Based’ Policies

Current, Former IRS Employees Took Thousands In Fraudulent COVID Relief, Spent It On Gucci, A Mercedes, And Trips To Vegas

Education Secretary Miguel Cardona: Students Need Access to Abortion to Thrive in School and in Life

Raphael Warnock’s Ex-Wife Accused Him of Injuring Her: He’s a ‘Great Actor’

Biden Must Resign, Period

Cori Bush Steps up to Spark More Democrat Midterm Election Infighting in Latest Interview

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”